All Industries

Top Biotech Companies

7,741 Biotech companies, sorted by total funding raised.

Verdiva Bio

Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative therap...

London, United Kingdom11–50Life Sciences, Biotech
Series ATotal funding$411.0MJan 2025
CStone PharmaceuticalsIPO

Innovation-driven biopharmaceutical company focused on immuno-oncology and molecularly targeted t...

Suzhou, China201–500Biotech, Healthcare
Series BTotal funding$410.0MMay 2018
Sonoma Biotherapeutics

Develops engineered regulatory T cell therapies to restore immune balance and treat autoimmune an...

Seattle, United States51–200Biotech, Life Sciences
Corporate RoundTotal funding$410.0MSep 2024
BillionToOneIPO

BillionToOne develops single-molecule diagnostic tests that improve prenatal screening and help c...

Menlo Park, United States201–500Biotech, Diagnostics
Venture RoundTotal funding$406.0MMar 2026
Mettler ToledoIPO

Mettler-Toledo is a global manufacturer of precision instruments and services for laboratory, ind...

Columbus, United States10001+Biotech, Manufacturing
Private EquityTotal funding$402.0MOct 1996
Leyden Labs

Leyden Labs is a clinical-stage biotech developing intranasal antibody sprays that block respirat...

Leiden, Netherlands11–50Biotech, Healthcare
Venture RoundTotal funding$401.6MJun 2026
Dianthus TherapeuticsIPO

Dianthus Therapeutics is a clinical-stage biotechnology company developing next-generation comple...

New York, United States11–50Biotech, Healthcare
Venture RoundTotal funding$400.0MSep 2023
Upstream BioIPO

Clinical-stage biotechnology company developing treatments for inflammatory diseases, with an ini...

Waltham, United States51–200Biotech, Healthcare
Series BTotal funding$400.0MJun 2023
Rhythm PharmaceuticalsIPO

Rhythm Pharmaceuticals develops precision medicines for patients with rare neuroendocrine disease...

Boston, United States201–500Biotech, Healthcare
Extension RoundTotal funding$398.0MJul 2025
VerastemIPO

Verastem Oncology advances novel small-molecule therapies targeting the RAS/MAPK signaling pathwa...

Boston, United States51–200Biotech, Healthcare
Corporate RoundTotal funding$392.5MNov 2025
SuperGenClosed

Pharmaceutical company dedicated to the discovery and development of novel cancer therapies.

Dublin, United States201–500Biotech
Corporate RoundTotal funding$391.6MOct 2009
Believer MeatsClosed

Believer develops cultivated meat production technology that grows animal cells in controlled con...

Chicago, United States51–200Biotech, Food Tech
Series BTotal funding$390.3MDec 2021
ReCode Therapeutics

ReCode develops precision-delivery genetic medicines, including mRNA and gene correction therapie...

Menlo Park, United States51–200Biotech, Healthcare
Venture RoundTotal funding$390.0MSep 2025
Synthekine

Biotechnology company engineering novel cytokines to advance immunology and develop next-generati...

Menlo Park, United States51–200Biotech, Healthcare
Series CTotal funding$389.5MSep 2023
Lyndra Therapeutics, Inc.Closed

R&D company with 4 SBIR/STTR awards from Department of Health and Human Services.

Watertown, United States51–200Biotech, Healthcare
Series ETotal funding$384.8MDec 2023
23andMeAcquired

23andMe analyzes customers' saliva samples to deliver genetic insights about ancestry, traits, an...

San Francisco Bay Area, United States501–1000Biotech, Healthcare
Series BTotal funding$382.5MDec 2020
Jade BiosciencesAcquired

Jade Biosciences develops potentially best-in-class therapies designed to transform care for pati...

Waltham, United States11–50Biotech, Healthcare
Corporate RoundTotal funding$380.0MApr 2025
AbSciIPO

Absci uses generative AI and wet-lab technologies to design biologic medicines faster for patient...

Vancouver, United States201–500Artificial Intelligence, Biotech
Growth EquityTotal funding$379.5MAug 2025
Inotrem

French clinical-stage biopharmaceutical company developing TREM-1 inhibition therapies, including...

Paris, France11–50Biotech
Series CTotal funding$379.3MOct 2022
ArcellxAcquired

Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable...

Redwood City, United States51–200Biotech, Healthcare
SeedTotal funding$375.0MJan 2024
SaludaIPO

Saluda Medical develops a neuromodulation platform that measures patient biomarkers and automatic...

Macquarie Park, AustraliaBiotech, Healthcare
Growth EquityTotal funding$375.0MJan 2025
AvalynIPO

Avalyn Pharma develops inhaled formulations of approved medicines to improve treatment benefits a...

Boston, United States11–50Biotech, Healthcare
Series DTotal funding$372.5MJul 2025
MapLight TherapeuticsIPO

AI-powered neuroscience drug discovery platform for CNS diseases.

San Francisco, United States51–200Artificial Intelligence, Biotech
Series DTotal funding$372.5MJul 2025
Formation Bio

Tech-native pharma company acquiring and developing clinical-stage assets via proprietary sourcin...

New York, United States51–200Artificial Intelligence, Biotech
Series DTotal funding$372.0MJun 2024
Definium Therapeutics, Inc. Common SharesIPO

Definium Therapeutics develops late-stage psychiatric medicines, applying rigorous clinical resea...

New York, United States11–50Biotech, Healthcare
Corporate RoundTotal funding$371.0MAug 2023